Coronary CT Angiography with Photon-Counting CT: First-In-Human Results
Salim Aymeric Si-Mohamed, Sara Boccalini, Hélène Lacombe, Alexia Diaw · Prospective comparative study
BlueRipple Assessment
This first-in-human study compared coronary CT angiography (CCTA) image quality and diagnostic confidence between photon-counting CT (PCCT) — a next-generation CT technology — and conventional energy-integrating detector (EID) CT with deep-learning reconstruction in 14 patients.
Photon-counting CT produced superior image quality scores and diagnostic confidence for coronary artery visualization, with higher spatial resolution, better delineation of calcifications, improved visualization of stent lumens, and superior noncalcified plaque characterization compared with EID CT. Phantom experiments quantified the detection index improvement at 40–60% over the comparator.
Photon-counting CT represents a fundamental advance in CT technology: by directly counting individual X-ray photons rather than measuring integrated energy, PCCT eliminates electronic noise and enables true multi-energy imaging from a single acquisition. For coronary imaging, the practical benefits are higher spatial resolution (enabling plaque microstructure assessment), better stent visualization, spectral information for tissue characterization, and potentially lower contrast agent doses.
The n=14 scale limits clinical inference, and the study measures image quality rather than diagnostic accuracy for clinical outcomes. The technology is now commercially available in select high-volume centers and is being evaluated in larger clinical studies.
We rate the evidence moderate for this early study. A technically rigorous first-in-human PCCT CCTA comparison demonstrating clear image quality advantages — pointing toward photon-counting CT as the next-generation standard for coronary CT imaging.
The original source
Si-Mohamed SA, Boccalini S, Lacombe H, et al. Coronary CT Angiography with Photon-counting CT: First-In-Human Results. Radiology. 2022 May;303(2):303-313.
BlueRipple Health provides consumer education and research synthesis for informed health advocacy. This is not medical advice. Discuss all health decisions with a qualified clinician.